{"id":"W2950140656","doi":"10.1093/ndt/gfz106.fp482","title":"FP482EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER","year":2019,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Glucagon-like peptide-1; Glucagon; Glucagon-like peptide-2; Internal medicine; Peptide; Endocrinology; Diabetes mellitus; Intensive care medicine; Insulin; Type 2 diabetes; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001555766,0.0002048338,0.0004368612,0.00008134329,0.0001033422,0.00002419893,0.0001027286,0.00012862,0.000372971],"category_scores_gemma":[0.00001129531,0.0001449972,0.00004590775,0.0001758154,0.0001534682,0.000308848,0.00002054417,0.0001643514,0.0001085402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003653613,"about_ca_system_score_gemma":0.00005472363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001130143,"about_ca_topic_score_gemma":0.00186349,"domain_scores_codex":[0.9986575,0.0001309909,0.0002205507,0.0005363639,0.0001722503,0.0002823457],"domain_scores_gemma":[0.9988236,0.0005241596,0.00009325115,0.0003920454,0.00004769742,0.0001191898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01528138,0.0007494573,0.932476,0.0003272899,0.006148411,0.0009139368,0.006220843,0.0001472682,0.01295466,0.0002168676,0.0009979309,0.02356594],"study_design_scores_gemma":[0.01970907,0.002299998,0.7969738,0.00007703617,0.01431813,0.0002976019,0.001499244,0.003706743,0.001692193,0.0001845151,0.1586633,0.0005783103],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920182,0.001146146,0.0005975281,0.004387036,0.00007198415,0.0004000176,0.0002659256,0.00004810319,0.001065048],"genre_scores_gemma":[0.987574,0.005980277,0.0004333262,0.002432183,0.0001472036,0.0000197477,0.003134882,0.00001801533,0.0002603082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1576654,"threshold_uncertainty_score":0.5912816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04586588664891668,"score_gpt":0.3248893250956541,"score_spread":0.2790234384467374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}